CVS Pays $315 Million to Settle Opioid Prescription Claims

Prosecutors alleged CVS filled unnecessary opioid prescriptions that contributed to the opioid epidemic, and the company has agreed to pay $315 million to resolve the claims. CVS did not admit wrongdoing and a spokesperson said the company "strongly disagreed" with the allegations. The settlement follows a pattern of pharmacy chains facing government scrutiny over opioid dispensing practices, some of which implicate Medicaid pharmacy claims and billing controls. Details on the allocation of settlement funds and whether Medicaid programs will receive a share were not specified in the available reporting.

Pharmacy